AUTS2

The AUTS2 Gene: Unraveling Common Genetic Threads of Neurodevelopmental Disorders

In the complex tapestry of the human brain, scientists have uncovered intriguing connections between seemingly distinct neurological conditions. Recent research has found that despite their diverse clinical manifestations, many neurodevelopmental disorders share common genetic roots. These insights are paving the way for a deeper understanding of the intricate mechanisms underlying conditions like autism spectrum disorder, intellectual disability, ADHD, and more.

AUTS2: The Maestro Gene of Neurodevelopmental Disorders

At the forefront of this exploration lies the AUTS2 gene—a pivotal player in the orchestra of neurodevelopment. AUTS2 isn’t just any gene; it’s a high-level regulator, a maestro directing the symphony of neuron formation and the crucial wiring of synaptic connections within the brain. AUTS2 doesn’t operate statically; instead, it springs into action within specific cells and in a specific sequence as the brain undergoes its remarkable journey from infancy to adulthood.

Moreover, AUTS2 does even more than conduct. It’s a complex gene that also creates different proteins. When something goes awry with one of these proteins, it can set the stage for a diverse array of neurological disorders, such as autism spectrum disorder, intellectual disability, ADHD, feeding disorders, epilepsy, and even susceptibility to addiction.

“This research isn’t just about unraveling the secrets of a gene; it’s about offering hope for a better understanding of neurodevelopmental disorders. It’s a step closer to personalized therapies and interventions that could potentially change lives.”

Lisa Stubbs, PhD
PNRI Senior Investigator and Interim Chief Scientific Officer

Exploring the Genetic Network: Downstream Effects of AUTS2

Enter the Stubbs Lab at PNRI, where the goal isn’t just to peek into the world of AUTS2—it’s to understand its nuances at a molecular level. The Stubbs Lab is on a quest to unravel the distinct functions of AUTS2 protein isoforms, or variations of the proteins that the AUTS2 gene creates. 

“This research isn’t just about unraveling the secrets of a gene; it’s about offering hope for a better understanding of neurodevelopmental disorders,” noted Lisa Stubbs, PhD, PNRI Senior Investigator and Interim Chief Scientific Officer. “It’s a step closer to personalized therapies and interventions that could potentially change lives.”

Dr. Stubbs and her team are especially interested in the hierarchy, or genetic network, of “downstream” genes controlled by high-level, master regulators like AUTS2. These downstream genes do not function properly when AUTS2 is mutated.  Mutations in these genes, especially the ones just below AUTS2 and higher in the network, cause very similar diseases to AUTS2 syndrome (a rare genetic disorder causing developmental delay and intellectual disability). 

Intriguingly, the AUTS2 isoforms each appear to impact some, but not all, of the parts of the genetic network, leading to different subsets of symptoms.  Mutations that affect more than one isoform impact the full genetic network, which causes severe disease. However, mutations that affect only one of the isoforms are linked to a specific subset of symptoms. Each isoform directs a hierarchy of downstream genes, some overlapping and some distinct; many downstream genes are also independently associated with neurological disorders and disease, usually reflecting a subset of AUTS2-related symptoms.

The further down the hierarchy a gene is, the more specific the disease symptoms get.  For example, some genes might be linked only to ADHD; some might be associated only with language difficulties, social awkwardness, or anxiety. These downstream genes can, therefore, highlight the biological causes of specific aspects AUTS2-linked disease – the molecular pathways that are disturbed in the patients – more directly, and yield information about how certain symptoms might be treated or ameliorated.  

A Pathway to Solutions: Interconnectedness in Neurological Conditions

This network concept might help explain why AUTS2 mutation leads to such a broad array of symptoms. The Stubbs Lab has identified and is planning to study some of these downstream genes because they may offer more specific routes to treatment.

As scientists continue to peel back the layers of complexity within our brains, one thing becomes crystal clear: the interconnectedness of seemingly distinct neurological conditions isn’t a barrier but a pathway toward greater comprehension and, ultimately, targeted solutions.

Stay tuned as the Stubbs Lab and researchers worldwide delve deeper into the world of AUTS2, unlocking the secrets that hold the potential to reshape our understanding of neurodevelopmental disorders as we know them.